STATUS™ COVID-19/Flu A&B Rapid Antigen Test


  • Sample Type: nasopharyngeal swab specimens
  • Detection Method: Colloidal Gold
  • Detection Time: 15 minutes
  • COVID-19 – Anterior Nasal – Sensitivity 93.8%, Specificity 100%
  • Nasopharyngeal – Sensitivity 93.1%, Specificity 100%
    • Flu A – Sensitivity 91.4%, Specificity 95.7%
    • Flu B – Sensitivity 87.6%, Specificity 95.9%
  • All necessary reagents provided and no equipment is needed
Categories: ,


Status™ COVID-19/Flu A&B test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and/or influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five days of onset of symptoms.

Interpretation of results: